Novel mutations associated with pyruvate kinase deficiency in Brazil

AUTOR(ES)

Svidnicki, Maria Carolina Costa Melo, Santos, Andrey, Fernandez, Jhonathan Angel Araujo, Yokoyama, Ana Paula Hitomi, Magalhães, Isis Quezado, Pinheiro, Vitoria Regia Pereira, Brandalise, Silvia Regina, Silveira, Paulo Augusto Achucarro, Costa, Fernando Ferreira, Saad, Sara Teresinha Olalla

FONTE

Hematol., Transfus. Cell Ther.

DATA DE PUBLICAÇÃO

2018-03

RESUMO

Abstract Background: Pyruvate kinase deficiency is a hereditary disease that affects the glycolytic pathway of the red blood cell, causing nonspherocytic hemolytic anemia. The disease is transmitted as an autosomal recessive trait and shows a marked variability in clinical expression. This study reports on the molecular characterization of ten Brazilian pyruvate kinase-deficient patients and the genotype–phenotype correlations. Method: Sanger sequencing and in silico analysis were carried out to identify and characterize the genetic mutations. A non-affected group of Brazilian individuals were also screened for the most commonly reported variants (c.1456C>T and c.1529G>A). Results: Ten different variants were identified in the PKLR gene, of which three are reported here for the first time: p.Leu61Gln, p.Ala137Val and p.Ala428Thr. All the three missense variants involve conserved amino acids, providing a rationale for the observed enzyme deficiency. The allelic frequency of c.1456C>T was 0.1% and the 1529G>A variant was not found. Conclusion: This is the first comprehensive report on molecular characterization of pyruvate kinase deficiency from South America. The results allowed us to correlate the severity of the clinical phenotype with the identified variants.

Documentos Relacionados

• Pyruvate kinase deficiency: novel mutations and a better understanding of the genotype-to-phenotype correlation in Brazilian patients
• Analysis of pyruvate kinase-deficiency mutations that produce nonspherocytic hemolytic anemia.
• A monomeric form of pyruvate kinase in human pyruvate kinase deficiency.
• Clinical heterogeneity and novel mutations in the glycerol kinase gene in three families with isolated glycerol kinase deficiency.
• Selective reticulocyte destruction in erythrocyte pyruvate kinase deficiency